391 related articles for article (PubMed ID: 30363010)
1. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause.
Biehl C; Plotsker O; Mirkin S
Menopause; 2019 Apr; 26(4):431-453. PubMed ID: 30363010
[TBL] [Abstract][Full Text] [Related]
2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
3. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
5. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Edwards D; Panay N
Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
[TBL] [Abstract][Full Text] [Related]
6. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
Potter N; Panay N
Climacteric; 2021 Feb; 24(1):19-24. PubMed ID: 32990054
[TBL] [Abstract][Full Text] [Related]
7. Genitourinary Syndrome of Menopause.
Shifren JL
Clin Obstet Gynecol; 2018 Sep; 61(3):508-516. PubMed ID: 29787390
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials.
Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082
[TBL] [Abstract][Full Text] [Related]
9. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
Tan O; Bradshaw K; Carr BR
Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
[TBL] [Abstract][Full Text] [Related]
10. Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review.
Casiano Evans EA; Hobson DTG; Aschkenazi SO; Alas AN; Balgobin S; Balk EM; Dieter AA; Kanter G; Orejuela FJ; Sanses TVD; Rahn DD
Obstet Gynecol; 2023 Sep; 142(3):555-570. PubMed ID: 37543737
[TBL] [Abstract][Full Text] [Related]
11. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
Sinha A; Ewies AA
Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
[TBL] [Abstract][Full Text] [Related]
12. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
[TBL] [Abstract][Full Text] [Related]
13. Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy.
Bruyniks N; Biglia N; Palacios S; Mueck AO
Climacteric; 2017 Jun; 20(3):195-204. PubMed ID: 28267367
[TBL] [Abstract][Full Text] [Related]
14. Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA; Crider M; Hill SR
Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
[TBL] [Abstract][Full Text] [Related]
15. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
Paton DM
Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
[TBL] [Abstract][Full Text] [Related]
16. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.
Buck ES; Lukas VA; Rubin RS
Urology; 2021 May; 151():31-36. PubMed ID: 32533967
[TBL] [Abstract][Full Text] [Related]
17. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review.
Dos Santos CCM; Uggioni MLR; Colonetti T; Colonetti L; Grande AJ; Da Rosa MI
J Sex Med; 2021 Jan; 18(1):156-166. PubMed ID: 33293236
[TBL] [Abstract][Full Text] [Related]
19. Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
Mueck AO; Ruan X; Prasauskas V; Grob P; Ortmann O
Climacteric; 2018 Apr; 21(2):140-147. PubMed ID: 29381086
[TBL] [Abstract][Full Text] [Related]
20. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment.
Mili N; Paschou SA; Armeni A; Georgopoulos N; Goulis DG; Lambrinoudaki I
Menopause; 2021 Mar; 28(6):706-716. PubMed ID: 33739315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
